Long-Term Persistence of Infection in Chimpanzees Inoculated with an Infectious Hepatitis C Virus Clone Is Associated with a Decrease in the Viral Amino Acid Substitution Rate and Low Levels of Heterogeneity
暂无分享,去创建一个
C. Rice | Duncan R. Morhardt | M. Major | M. Puig | Deborah R. Taylor | S. Feinstone | K. Mihalik | J. Fernández
[1] M. Major,et al. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection. , 2004, Vaccine.
[2] Charles M. Rice,et al. HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help , 2003, Science.
[3] C. Cheng‐Mayer,et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Bartosch,et al. Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes , 2003, The Journal of experimental medicine.
[5] M. Major,et al. Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay. , 2002, Journal of virological methods.
[6] Stephen J. Merrill,et al. Sequence Variation in the Gene Encoding the Nonstructural 3 Protein of Hepatitis C Virus: Evidence for Immune Selection , 2002, Journal of Molecular Evolution.
[7] A. Hughes,et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.
[8] G. Deléage,et al. Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment , 2001, Journal of Virology.
[9] C. Rice,et al. Efficient initiation of HCV RNA replication in cell culture. , 2000, Science.
[10] S. Emerson,et al. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] H J Alter,et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.
[12] O. Laeyendecker,et al. Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees , 2000, Journal of Virology.
[13] D. Smith,et al. Evolution of the hypervariable region of hepatitis C virus , 1999, Journal of viral hepatitis.
[14] D. Eckels,et al. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. , 1999, Journal of immunology.
[15] C. Rice,et al. Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus , 1999, Journal of Virology.
[16] O. Laeyendecker,et al. Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.
[17] A. Sette,et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.
[18] C. Rice,et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. , 1997, Science.
[19] H. Yagita,et al. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope , 1997, European journal of immunology.
[20] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Purcell,et al. Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.
[22] L. van Doorn,et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses , 1995, Journal of virology.
[23] E. Holmes,et al. A proposed system for the nomenclature of hepatitis C viral genotypes , 1994, Hepatology.
[24] R. Purcell,et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses , 1994, Journal of virology.
[25] A. Weiner,et al. Vaccination of chimpanzees against infection by the hepatitis C virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] N. Enomoto,et al. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection , 1993, Hepatology.
[27] S. Mishiro,et al. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients , 1992, Hepatology.
[28] R. Purcell,et al. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Onji,et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Houghton,et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.
[31] C. Rice,et al. The Hepatitis C Viruses , 2000, Current Topics in Microbiology and Immunology.